Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.

J. Zoldan, G. Friedberg, A. Weizman, E. Melamed

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)541-544
Number of pages4
JournalAdvances in neurology
Volume69
StatePublished - 1996
Externally publishedYes

Cite this